Testing effectiveness (Phase 2)Ended earlyNCT03448692
What this trial is testing
Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)
Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Pfizer 47
Showing 20 of 117 results